136 related articles for article (PubMed ID: 27429102)
1. Diagnostics and treatment of a severe humoral rejection after liver transplantation: donor-specific antibodies as a still underestimated cause of graft failure.
Rashidi-Alavijeh J; Heinold A; Willuweit K; Baba HA; Horn PA; Paul A; Witzke O; Gerken G; Herzer K
Z Gastroenterol; 2016 Jul; 54(7):647-52. PubMed ID: 27429102
[TBL] [Abstract][Full Text] [Related]
2. De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients.
Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Cardeau-Desangles I; Guitard J; Dörr G; Milongo D; Suc B; Duffas JP; Alric L; Bureau C; Guilbeau-Frugier C; Rostaing L; Kamar N
Transpl Int; 2015 Dec; 28(12):1371-82. PubMed ID: 26303035
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.
Musat AI; Pigott CM; Ellis TM; Agni RM; Leverson GE; Powell AJ; Richards KR; D'Alessandro AM; Lucey MR
Liver Transpl; 2013 Oct; 19(10):1132-41. PubMed ID: 23873778
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of the de novo production of anti-HLA antibodies following intestinal and multivisceral transplantation.
Gerlach UA; Lachmann N; Sawitzki B; Arsenic R; Neuhaus P; Schoenemann C; Pascher A
Transpl Int; 2014 Mar; 27(3):280-9. PubMed ID: 24279605
[TBL] [Abstract][Full Text] [Related]
6. Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation.
O'Leary JG; Kaneku H; Jennings LW; Bañuelos N; Susskind BM; Terasaki PI; Klintmalm GB
Liver Transpl; 2013 Sep; 19(9):973-80. PubMed ID: 23780820
[TBL] [Abstract][Full Text] [Related]
7. Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in children.
Petit LM; Rabant M; Canioni D; Suberbielle-Boissel C; Goulet O; Chardot C; Lacaille F
Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 28084679
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, Risk Factors, and Impact of Donor-Specific Alloantibodies After Adult Liver Transplantation.
Vandevoorde K; Ducreux S; Bosch A; Guillaud O; Hervieu V; Chambon-Augoyard C; Poinsot D; André P; Scoazec JY; Robinson P; Boillot O; Dubois V; Dumortier J
Liver Transpl; 2018 Aug; 24(8):1091-1100. PubMed ID: 29665189
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature.
Kheradmand T; Anthony TL; Harland RC; Testa G; Hart J; Renz J; Te HS; Marino SR
Hum Immunol; 2014 Jun; 75(6):578-83. PubMed ID: 24530823
[TBL] [Abstract][Full Text] [Related]
10. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts.
Miyagawa-Hayashino A; Yoshizawa A; Uchida Y; Egawa H; Yurugi K; Masuda S; Minamiguchi S; Maekawa T; Uemoto S; Haga H
Liver Transpl; 2012 Nov; 18(11):1333-42. PubMed ID: 22888064
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.
Cuadrado A; San Segundo D; López-Hoyos M; Crespo J; Fábrega E
World J Gastroenterol; 2015 Oct; 21(39):11016-26. PubMed ID: 26494958
[TBL] [Abstract][Full Text] [Related]
12. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
Dragun D; Catar R; Philippe A
Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
[TBL] [Abstract][Full Text] [Related]
13. Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report.
Nakano R; Ohira M; Ishiyama K; Ide K; Kobayashi T; Tahara H; Shimizu S; Arihiro K; Imamura M; Chayama K; Tanaka Y; Ohdan H
Transplant Proc; 2017 Sep; 49(7):1634-1638. PubMed ID: 28838454
[TBL] [Abstract][Full Text] [Related]
14. Anti-human leukocyte antigen immunization after early allograft nephrectomy.
Del Bello A; Congy N; Sallusto F; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Game X; Blancher A; Rostaing L; Kamar N
Transplantation; 2012 May; 93(9):936-41. PubMed ID: 22361471
[TBL] [Abstract][Full Text] [Related]
15. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Impact of Reformed and De Novo Anti-HLA Donor-Specific Antibodies in Liver Transplantation.
Papachristou M; Fylaktou A; Daoudaki M; Cholongitas E; Karampatakis T; Anastasiou A; Chatzika G; Makrovasili F; Vagiotas L; Karakasi K; Fouzas I
Transplant Proc; 2019 Mar; 51(2):424-428. PubMed ID: 30879557
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression with mTOR inhibitors prevents the development of donor-specific antibodies after liver transplant.
Willuweit K; Heinold A; Rashidi-Alavijeh J; Heinemann FM; Horn PA; Paul A; Gerken G; Herzer K
Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28345271
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of donor-specific antibodies after B-cell depleting therapies to cure chronic antibody mediated rejection.
Touzot M; Couvrat-Desvergnes G; Castagnet S; Cesbron A; Renaudin K; Cantarovich D; Giral M
Transplantation; 2015 Jan; 99(1):63-8. PubMed ID: 25029384
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients.
Yamada C; Ramon DS; Cascalho M; Sung RS; Leichtman AB; Samaniego M; Davenport RD
Transfusion; 2015 Apr; 55(4):727-35; quiz 726. PubMed ID: 25385678
[TBL] [Abstract][Full Text] [Related]
20. Retransplant as Rescue Treatment for ABO-Compatible Living-Donor Liver Transplant Related Antibody-Mediated Rejection: A Case Report.
Ho MH; Wu SY; Ou KW; Su TF; Hsieh CB
Exp Clin Transplant; 2018 Apr; 16(2):222-226. PubMed ID: 26742858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
